In hematological malignancies, primary chronic lymphocytic leukemia patient samples were found to have PDE7B overexpression and noted to be sensitive to PDE7 inhibition in a cAMP‐dependent manner [38]. The gene discussed is PDE7A; the disease is B-cell chronic lymphocytic leukemia.